Obesity and non-alcoholic fatty liver disease personalized approaches to metabolic risks correction

Obesity and non-alcoholic fatty liver disease personalized approaches to metabolic risks correction

Nonalcoholic fatty liver disease (NAFLD) – a common chronic disease of the liver, the main feature of which is the accumulation of fat in hepatocytes, is not related to alcohol abuse. NAFLD is associated with obesity, especially abdominal, metabolic syndrome and various metabolic markers of risk for...

Full description

Bibliographic Details
Main Authors: K. A. Komshilova, E. A. Troshina
Format: Article
Language:Russian
Published: Remedium Group LLC 2018-04-01
Series:Медицинский совет
Subjects:
obesity
nonalcoholic fatty liver disease
insulin resistance
liraglutide
Online Access:https://www.med-sovet.pro/jour/article/view/2386
id doaj-7ac0023de9b047ef8aec48821b9de06c
record_format Article
spelling doaj-7ac0023de9b047ef8aec48821b9de06c2021-07-28T13:29:35ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902018-04-010613213610.21518/2079-701X-2018-6-132-1362361Obesity and non-alcoholic fatty liver disease personalized approaches to metabolic risks correctionK. A. Komshilova0E. A. Troshina1National Medical Research Center of Endocrinology of the Ministry of Health of Russia, MoscowNational Medical Research Center of Endocrinology of the Ministry of Health of Russia, MoscowNonalcoholic fatty liver disease (NAFLD) – a common chronic disease of the liver, the main feature of which is the accumulation of fat in hepatocytes, is not related to alcohol abuse. NAFLD is associated with obesity, especially abdominal, metabolic syndrome and various metabolic markers of risk for cardiovascular disease and type 2 diabetes, which affects the incidence, prognosis and life expectancy of patients with obesity. This lecture describes the main causes of the disease, its pathogenesis, clinical presentation, diagnosis and treatment.https://www.med-sovet.pro/jour/article/view/2386obesitynonalcoholic fatty liver diseaseinsulin resistanceliraglutide
collection DOAJ
language Russian
format Article
sources DOAJ
author K. A. Komshilova
E. A. Troshina
spellingShingle K. A. Komshilova
E. A. Troshina
Obesity and non-alcoholic fatty liver disease personalized approaches to metabolic risks correction
Медицинский совет
obesity
nonalcoholic fatty liver disease
insulin resistance
liraglutide
author_facet K. A. Komshilova
E. A. Troshina
author_sort K. A. Komshilova
title Obesity and non-alcoholic fatty liver disease personalized approaches to metabolic risks correction
title_short Obesity and non-alcoholic fatty liver disease personalized approaches to metabolic risks correction
title_full Obesity and non-alcoholic fatty liver disease personalized approaches to metabolic risks correction
title_fullStr Obesity and non-alcoholic fatty liver disease personalized approaches to metabolic risks correction
title_full_unstemmed Obesity and non-alcoholic fatty liver disease personalized approaches to metabolic risks correction
title_sort obesity and non-alcoholic fatty liver disease personalized approaches to metabolic risks correction
publisher Remedium Group LLC
series Медицинский совет
issn 2079-701X
2658-5790
publishDate 2018-04-01
description Nonalcoholic fatty liver disease (NAFLD) – a common chronic disease of the liver, the main feature of which is the accumulation of fat in hepatocytes, is not related to alcohol abuse. NAFLD is associated with obesity, especially abdominal, metabolic syndrome and various metabolic markers of risk for cardiovascular disease and type 2 diabetes, which affects the incidence, prognosis and life expectancy of patients with obesity. This lecture describes the main causes of the disease, its pathogenesis, clinical presentation, diagnosis and treatment.
topic obesity
nonalcoholic fatty liver disease
insulin resistance
liraglutide
url https://www.med-sovet.pro/jour/article/view/2386
work_keys_str_mv AT kakomshilova obesityandnonalcoholicfattyliverdiseasepersonalizedapproachestometabolicriskscorrection
AT eatroshina obesityandnonalcoholicfattyliverdiseasepersonalizedapproachestometabolicriskscorrection
_version_ 1721274045005037568

Similar Items